3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Renal Cell
23
Neoplasms
14
Neoplasm Metastasis
14
Glioblastoma
14
Prostatic Neoplasms
13
Breast Neoplasms
11
Brain Neoplasms
11
Sarcoma
10
Lymphoma, Non-Hodgkin
10
Kidney Neoplasms
10
Endometrial Neoplasms
10
Melanoma
9
Lymphoma, Mantle-Cell
9
Gliosarcoma
8
Multiple Myeloma
7
Glioma
7
Ovarian Neoplasms
6
Carcinoma, Hepatocellular
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Oligodendroglioma
5
Lymphoma, Follicular
5
Lymphoma
5
Hodgkin Disease
5
Central Nervous System Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Astrocytoma
5
Waldenstrom Macroglobulinemia
4
Uterine Cervical Neoplasms
4
Unspecified Adult Solid Tumor, Protocol Specific
4
Rhabdomyosarcoma
4
Interventions
temsirolimus
1
tegafur-gimeracil-oteracil
1
S 1 (combination)
1
Oxaliplatin
1
Epirubicin
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Patients With Advanced or Metastatic Solid Tumors
×
temsirolimus
×
Clear all
NCT02215720
2026-03-20
TORERO
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1
Completed
45 enrolled